February 20, 2018 GenSight Biologics announces publication of positive data from Phase I/II trial and long-term follow-up of GS010 in Ophthalmology, the journal of the American Academy of Ophthalmology
February 20, 2018 Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2017 Results Presentation and Webcast
February 19, 2018 SAVE THE DATE: Wilson Therapeutics to Host Capital Markets Day in Stockholm on 21 March 2018
February 16, 2018 First patient enrolled in pivotal Phase 3 FOCuS trial evaluating WTX101 for the treatment of Wilson Disease
February 14, 2018 Pulmonx’ endobronchial valve technology explained by American Journal of Respiratory and Critical Care Medicine